Melomet Use In Pregnancy & Lactation

Use in pregnancy: There is inadequate evidence to support the safety use in human pregnancy. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate and intra-uterine growth retardation. There may therefore be a very small risk of such effects in the human foetus. It should be used during pregnancy only if the potential benefit justifies potential risk to the mother or the fetus.
Cream: Drugs of this class should not be used on pregnant patients in large amounts or for prolonged periods of time.
Lotion: During pregnancy treatment with Melomet Lotion 0.1% w/w should be performed only on the physician's order. Then however, the application on large body surface areas over a prolonged period should be avoided.
However as with all topically applied glucocorticoids, the possibility that fetal growth may be affected by glucocorticoid passage through the placental barrier should be considered.
Use in lactation: It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk.
Cream: Caution should be exercised when Melomet cream is administered to a nursing mother.
Lotion: Melomet Lotion 0.1% w/w should be administered to nursing mothers only after careful consideration of the benefit/risk relationship. If treatment with higher doses or long-term application is indicated, breast-feeding should be discontinued.